• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Invesco Biotechnology & Genome ETF (NY:PBE)

96.08 -2.57 (-2.61%)
Official Closing Price Updated: 8:00 PM EDT, Oct 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 11,157
Open 98.27
Bid (Size) 95.20 (3,200)
Ask (Size) 97.19 (3,100)
Prev. Close 98.65
Today's Range 95.92 - 98.27
52wk Range 71.53 - 99.30
Shares Outstanding 34,500
Dividend Yield 0.08%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Which Healthcare ETF Is the Better Buy: Fidelity’s Broad FHLC or Invesco’s Biotech-Focused PBE? ↗
October 11, 2026
One offers broad diversification at 0.08% cost, while the other targets concentrated biotech growth with higher volatility. 
Via The Motley Fool
Topics ETFs
News headline image
PBE vs. RSPH: Is a Biotech ETF or Equal-Weight Healthcare ETF the Better Choice for Investors? ↗
September 15, 2026
PBE offers higher income and stronger returns, while RSPH provides broader diversification with lower costs and drawdown risk. 
Via The Motley Fool
Topics ETFs

Performance

52-Week Range 3.2% below 52-week high
96.08
71.5352W Low 99.3052W High
1 Week 3.2% below 1-week high
94.751W Low 99.301W High

Invesco Biotechnology & Genome ETF (PBE) traded between $71.53 and $99.30 over the past 52 weeks and last traded at $96.08, 3.2% below its 52-week high. Over the past week it ranged between $94.75 and $99.30.

Past 12 Months
-0.4%
+0.4%
+7.1%
+17.8%
+16.7%
+33.0%
1W -$0.36
1M +$0.41
3M +$6.40
6M +$14.54
YTD +$13.73
1Y +$23.85

PBE was +33.0% over the past year, +17.8% over six months, +16.7% year to date, -0.4% in the last week.

12 Months vs Market
PBE
+33.0%
DIA
+12.4%
SPY
+14.9%
QQQ
+17.5%
IWM
+11.1%

Over the past 12 months PBE returned +33.0% versus DIA (Dow) +12.4%, SPY (S&P 500) +14.9%, QQQ (Nasdaq 100) +17.5% and IWM (Russell 2000) +11.1%.

Volume & Liquidity 0.39× 3-mo avg
Today 11,157 3-mo avg 28.3K
1W
10.9K
1M
12.6K
3M
28.3K
6M
17.4K
YTD
13.8K
1Y
12.2K

PBE most recently traded 11,157 shares against a 3-month average daily volume of 28.3K.

More News

Read More
News headline image
iShares' IYH or Invesco's PBE: Which Healthcare ETF Is the Better Long-Term Buy? ↗
September 09, 2026
Via The Motley Fool
Topics ETFs
MannKind Stock Soared 8% Today: Why A Surge In Afrezza Inhaled Insulin Sales Matters ↗
November 05, 2025
Via Stocktwits
Akebia Therapeutics Stock Slumps After FDA Meeting Ends Without Path Forward for Vafseo Label Expansion ↗
October 29, 2025
Via Stocktwits
Ionis Pharma Stock Rises After Multiple Price Target Hikes On Heels Of Positive Study Results In Alexander Disease ↗
September 23, 2025
Via Stocktwits
News headline image
Pharma ETF or Biotech ETF: Which Matches Your Investing Mindset? ↗
August 21, 2026
Via The Motley Fool
Topics ETFs
News headline image
IBBQ vs. PBE: Which Biotech ETF Is the Better Buy? ↗
August 21, 2026
Via The Motley Fool
Topics ETFs
News headline image
VanEck Pharmaceutical ETF vs. Invesco Biotech ETF: Which Fund Fits Your Investing Style? ↗
August 12, 2026
Via The Motley Fool
Topics ETFs
News headline image
XLV vs PBE: Is a Low-Cost Healthcare ETF the Better Buy Than a Focused Biotech Specialist? ↗
August 01, 2026
Via The Motley Fool
Topics ETFs
News headline image
VHT vs. PBE: Which Health Care ETF Is the Better Buy? ↗
July 30, 2026
Via The Motley Fool
Topics ETFs
News headline image
Why Did MNKD Stock Jump Over 7% In Pre-Market Today? ↗
January 26, 2026
Via Stocktwits
News headline image
Pharma ETFs In A Tariff Storm: How Investors Can Hedge Risk ↗
September 29, 2025
Via Benzinga
Topics ETFs
News headline image
3 Biotech Stocks to Buy That Have CRISPR-Like Breakthrough Potential ↗
February 19, 2024
Via InvestorPlace
News headline image
Mifepristone Abortion Pill Access in Limbo: Justice Department May Ask Supreme Court's Intervention ↗
April 13, 2023
Via Benzinga
News headline image
Women's Reproductive Rights: US Court Preserves Access To Abortion Pill For Now, But With Tighter Rules ↗
April 13, 2023
Via Benzinga
News headline image
New York and California Prepare For Potential Mifepristone Ban In Texas With Stockpiling Of Alternative Abortion Medications ↗
April 12, 2023
Via Benzinga
News headline image
Attorney Generals of Over 20 States Sound Alarm Over Suspension Of Abortion Med Approval: "Devastating Risks" Ahead ↗
April 11, 2023
Via Benzinga
News headline image
FDA Withdraws Lone Premature Birth Drug Makena Over Lack of Proven Benefits ↗
April 06, 2023
Via Benzinga
News headline image
US Judge Weighs Nationwide Ban On Abortion Pills ↗
March 16, 2023
Via Benzinga
News headline image
FDA Takes Action To Restrict Unlawful Import Of Animal Tranquilizer 'Tranq' Or ''Zombie Drug' ↗
March 01, 2023
Via Benzinga
News headline image
7 Best Biotech Stocks to Buy in July 2022 ↗
July 08, 2022
Via InvestorPlace
News headline image
Biotech ETFs That Outperformed Last Week ↗
December 20, 2021
Via Talk Markets
News headline image
A Comprehensive Guide To Genomic ETFs ↗
July 11, 2021
Via Talk Markets
News headline image
5 Top ETFs With Exposure To Biogen ↗
June 07, 2021
Via Talk Markets

Frequently Asked Questions

Is Invesco Biotechnology & Genome ETF publicly traded?
Yes, Invesco Biotechnology & Genome ETF is publicly traded.
What exchange does Invesco Biotechnology & Genome ETF trade on?
Invesco Biotechnology & Genome ETF trades on the New York Stock Exchange
What is the ticker symbol for Invesco Biotechnology & Genome ETF?
The ticker symbol for Invesco Biotechnology & Genome ETF is PBE on the New York Stock Exchange
What is the current price of Invesco Biotechnology & Genome ETF?
The current price of Invesco Biotechnology & Genome ETF is 96.08
When was Invesco Biotechnology & Genome ETF last traded?
The last trade of Invesco Biotechnology & Genome ETF was at 10/16/26 08:00 PM ET
What is the market capitalization of Invesco Biotechnology & Genome ETF?
The market capitalization of Invesco Biotechnology & Genome ETF is 3.31M
How many shares of Invesco Biotechnology & Genome ETF are outstanding?
Invesco Biotechnology & Genome ETF has 3M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap